Advanced search options

Advanced Search Options 🞨

Browse by author name (“Author name starts with…”).

Find ETDs with:

in
/  
in
/  
in
/  
in

Written in Published in Earliest date Latest date

Sorted by

Results per page:

Sorted by: relevance · author · university · dateNew search

You searched for subject:(Cancer stem cells EGFR phosphorylation lung cancer). Showing records 1 – 30 of 47453 total matches.

[1] [2] [3] [4] [5] … [1582]

Search Limiters

Last 2 Years | English Only

Degrees

Levels

Languages

Country

▼ Search Limiters

1. Salvati, Valentina. Development of effective lung cancer therapies based on lung cancer stem cella targeting.

Degree: 2015, Università degli Studi di Catania

 Il carcinoma polmonare non a piccole cellule (NSCLC) rappresenta circa l 80% di tutti i tumori al polmone ed è il cancro più comune e… (more)

Subjects/Keywords: Area 05 - Scienze biologiche; Cancer stem cells, EGFR phosphorylation, lung cancer

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Salvati, V. (2015). Development of effective lung cancer therapies based on lung cancer stem cella targeting. (Thesis). Università degli Studi di Catania. Retrieved from http://hdl.handle.net/10761/4035

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Salvati, Valentina. “Development of effective lung cancer therapies based on lung cancer stem cella targeting.” 2015. Thesis, Università degli Studi di Catania. Accessed September 19, 2019. http://hdl.handle.net/10761/4035.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Salvati, Valentina. “Development of effective lung cancer therapies based on lung cancer stem cella targeting.” 2015. Web. 19 Sep 2019.

Vancouver:

Salvati V. Development of effective lung cancer therapies based on lung cancer stem cella targeting. [Internet] [Thesis]. Università degli Studi di Catania; 2015. [cited 2019 Sep 19]. Available from: http://hdl.handle.net/10761/4035.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Salvati V. Development of effective lung cancer therapies based on lung cancer stem cella targeting. [Thesis]. Università degli Studi di Catania; 2015. Available from: http://hdl.handle.net/10761/4035

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


Vanderbilt University

2. Meador, Catherine Belle. Optimizing the sequence of targeted therapy in EGFR-mutant lung adenocarcinoma.

Degree: PhD, Cancer Biology, 2015, Vanderbilt University

EGFR-mutant lung cancers are highly sensitive to EGFR tyrosine kinase inhibitors (TKIs; erlotinib/gefitinib/afatinib), but tumors develop drug resistance within 9-16 months. Resistance to gefitinib/erlotinib commonly… (more)

Subjects/Keywords: targeted therapy; EGFR; lung cancer

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Meador, C. B. (2015). Optimizing the sequence of targeted therapy in EGFR-mutant lung adenocarcinoma. (Doctoral Dissertation). Vanderbilt University. Retrieved from http://etd.library.vanderbilt.edu/available/etd-07202015-172236/ ;

Chicago Manual of Style (16th Edition):

Meador, Catherine Belle. “Optimizing the sequence of targeted therapy in EGFR-mutant lung adenocarcinoma.” 2015. Doctoral Dissertation, Vanderbilt University. Accessed September 19, 2019. http://etd.library.vanderbilt.edu/available/etd-07202015-172236/ ;.

MLA Handbook (7th Edition):

Meador, Catherine Belle. “Optimizing the sequence of targeted therapy in EGFR-mutant lung adenocarcinoma.” 2015. Web. 19 Sep 2019.

Vancouver:

Meador CB. Optimizing the sequence of targeted therapy in EGFR-mutant lung adenocarcinoma. [Internet] [Doctoral dissertation]. Vanderbilt University; 2015. [cited 2019 Sep 19]. Available from: http://etd.library.vanderbilt.edu/available/etd-07202015-172236/ ;.

Council of Science Editors:

Meador CB. Optimizing the sequence of targeted therapy in EGFR-mutant lung adenocarcinoma. [Doctoral Dissertation]. Vanderbilt University; 2015. Available from: http://etd.library.vanderbilt.edu/available/etd-07202015-172236/ ;


University of New South Wales

3. Luk, Peter Ping-Kit. The influence of the EGFR pathway in modulating the efficacy of gemcitabine.

Degree: Clinical School - St George Hospital, 2011, University of New South Wales

 Multiple anti-cancer drugs are often combined to increase their effectiveness. This study investigates the combination between an epidermal growth factor receptor (EGFR) inhibitor and gemcitabine,… (more)

Subjects/Keywords: Lung cancer; Gemcitabine; EGFR

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Luk, P. P. (2011). The influence of the EGFR pathway in modulating the efficacy of gemcitabine. (Doctoral Dissertation). University of New South Wales. Retrieved from http://handle.unsw.edu.au/1959.4/50384 ; https://unsworks.unsw.edu.au/fapi/datastream/unsworks:9271/SOURCE02?view=true

Chicago Manual of Style (16th Edition):

Luk, Peter Ping-Kit. “The influence of the EGFR pathway in modulating the efficacy of gemcitabine.” 2011. Doctoral Dissertation, University of New South Wales. Accessed September 19, 2019. http://handle.unsw.edu.au/1959.4/50384 ; https://unsworks.unsw.edu.au/fapi/datastream/unsworks:9271/SOURCE02?view=true.

MLA Handbook (7th Edition):

Luk, Peter Ping-Kit. “The influence of the EGFR pathway in modulating the efficacy of gemcitabine.” 2011. Web. 19 Sep 2019.

Vancouver:

Luk PP. The influence of the EGFR pathway in modulating the efficacy of gemcitabine. [Internet] [Doctoral dissertation]. University of New South Wales; 2011. [cited 2019 Sep 19]. Available from: http://handle.unsw.edu.au/1959.4/50384 ; https://unsworks.unsw.edu.au/fapi/datastream/unsworks:9271/SOURCE02?view=true.

Council of Science Editors:

Luk PP. The influence of the EGFR pathway in modulating the efficacy of gemcitabine. [Doctoral Dissertation]. University of New South Wales; 2011. Available from: http://handle.unsw.edu.au/1959.4/50384 ; https://unsworks.unsw.edu.au/fapi/datastream/unsworks:9271/SOURCE02?view=true


University of Cincinnati

4. Akunuru, Shailaja. Regulation of cancer stem cell activity and epithelial mesenchymal transition by Rac1 in Human lung adenocarcinoma cells.

Degree: PhD, Medicine: Molecular and Developmental Biology, 2011, University of Cincinnati

 The cancer stem cell (CSC) theory predicts that a small fraction of cancer cells possesses unique self-renewal, expansion and differentiation activities in tumorigenesis. While this… (more)

Subjects/Keywords: Cellular Biology; Cancer stem cells; EMT; Rac1; Metastasis; Lung cancer; NSCLA

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Akunuru, S. (2011). Regulation of cancer stem cell activity and epithelial mesenchymal transition by Rac1 in Human lung adenocarcinoma cells. (Doctoral Dissertation). University of Cincinnati. Retrieved from http://rave.ohiolink.edu/etdc/view?acc_num=ucin1314301864

Chicago Manual of Style (16th Edition):

Akunuru, Shailaja. “Regulation of cancer stem cell activity and epithelial mesenchymal transition by Rac1 in Human lung adenocarcinoma cells.” 2011. Doctoral Dissertation, University of Cincinnati. Accessed September 19, 2019. http://rave.ohiolink.edu/etdc/view?acc_num=ucin1314301864.

MLA Handbook (7th Edition):

Akunuru, Shailaja. “Regulation of cancer stem cell activity and epithelial mesenchymal transition by Rac1 in Human lung adenocarcinoma cells.” 2011. Web. 19 Sep 2019.

Vancouver:

Akunuru S. Regulation of cancer stem cell activity and epithelial mesenchymal transition by Rac1 in Human lung adenocarcinoma cells. [Internet] [Doctoral dissertation]. University of Cincinnati; 2011. [cited 2019 Sep 19]. Available from: http://rave.ohiolink.edu/etdc/view?acc_num=ucin1314301864.

Council of Science Editors:

Akunuru S. Regulation of cancer stem cell activity and epithelial mesenchymal transition by Rac1 in Human lung adenocarcinoma cells. [Doctoral Dissertation]. University of Cincinnati; 2011. Available from: http://rave.ohiolink.edu/etdc/view?acc_num=ucin1314301864

5. Svensson, Susanne. In vitro and in vivo inhibition of Chk1 sensitize lung cancer stem cells to chemotherapy.

Degree: 2011, Università degli Studi di Catania

 Development of resistance to radiation and chemotherapy turns the treatment of solid cancers into a therapeutic challenge. One of the most exciting breakthroughs being explored… (more)

Subjects/Keywords: Non-small cell lung cancer; Lung cancer stem cells; DNA damage; Chk1 inhibitors

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Svensson, S. (2011). In vitro and in vivo inhibition of Chk1 sensitize lung cancer stem cells to chemotherapy. (Thesis). Università degli Studi di Catania. Retrieved from http://hdl.handle.net/10761/98

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Svensson, Susanne. “In vitro and in vivo inhibition of Chk1 sensitize lung cancer stem cells to chemotherapy.” 2011. Thesis, Università degli Studi di Catania. Accessed September 19, 2019. http://hdl.handle.net/10761/98.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Svensson, Susanne. “In vitro and in vivo inhibition of Chk1 sensitize lung cancer stem cells to chemotherapy.” 2011. Web. 19 Sep 2019.

Vancouver:

Svensson S. In vitro and in vivo inhibition of Chk1 sensitize lung cancer stem cells to chemotherapy. [Internet] [Thesis]. Università degli Studi di Catania; 2011. [cited 2019 Sep 19]. Available from: http://hdl.handle.net/10761/98.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Svensson S. In vitro and in vivo inhibition of Chk1 sensitize lung cancer stem cells to chemotherapy. [Thesis]. Università degli Studi di Catania; 2011. Available from: http://hdl.handle.net/10761/98

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


Stellenbosch University

6. Van der Westhuyzen, Aletta Elizabeth. Synthesis of novel staurosporine analogues as potential kinase inhibitors.

Degree: MSc, Chemistry and Polymer Science, 2015, Stellenbosch University

ENGLISH ABSTRACT: Protein kinases are enzymes that promote phosphorylation – transferring a phosphate group from ATP to a substrate protein. Due to the central involvement… (more)

Subjects/Keywords: Protein kinases; EGFR; Cancer therapy; UCTD; Phosphorylation

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Van der Westhuyzen, A. E. (2015). Synthesis of novel staurosporine analogues as potential kinase inhibitors. (Masters Thesis). Stellenbosch University. Retrieved from http://hdl.handle.net/10019.1/96632

Chicago Manual of Style (16th Edition):

Van der Westhuyzen, Aletta Elizabeth. “Synthesis of novel staurosporine analogues as potential kinase inhibitors.” 2015. Masters Thesis, Stellenbosch University. Accessed September 19, 2019. http://hdl.handle.net/10019.1/96632.

MLA Handbook (7th Edition):

Van der Westhuyzen, Aletta Elizabeth. “Synthesis of novel staurosporine analogues as potential kinase inhibitors.” 2015. Web. 19 Sep 2019.

Vancouver:

Van der Westhuyzen AE. Synthesis of novel staurosporine analogues as potential kinase inhibitors. [Internet] [Masters thesis]. Stellenbosch University; 2015. [cited 2019 Sep 19]. Available from: http://hdl.handle.net/10019.1/96632.

Council of Science Editors:

Van der Westhuyzen AE. Synthesis of novel staurosporine analogues as potential kinase inhibitors. [Masters Thesis]. Stellenbosch University; 2015. Available from: http://hdl.handle.net/10019.1/96632


Boston University

7. Polio, Andrew. EGFR mutated lung cancer: current therapies and potential future treatments.

Degree: MS, Medical Sciences, 2015, Boston University

Lung cancer is the leading cause of cancer related deaths in the United States, with an estimated 158, 040 deaths in 2015, accounting for 27%… (more)

Subjects/Keywords: Medicine; EGFR; NSCLC; Lung cancer; Target therapy

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Polio, A. (2015). EGFR mutated lung cancer: current therapies and potential future treatments. (Masters Thesis). Boston University. Retrieved from http://hdl.handle.net/2144/13957

Chicago Manual of Style (16th Edition):

Polio, Andrew. “EGFR mutated lung cancer: current therapies and potential future treatments.” 2015. Masters Thesis, Boston University. Accessed September 19, 2019. http://hdl.handle.net/2144/13957.

MLA Handbook (7th Edition):

Polio, Andrew. “EGFR mutated lung cancer: current therapies and potential future treatments.” 2015. Web. 19 Sep 2019.

Vancouver:

Polio A. EGFR mutated lung cancer: current therapies and potential future treatments. [Internet] [Masters thesis]. Boston University; 2015. [cited 2019 Sep 19]. Available from: http://hdl.handle.net/2144/13957.

Council of Science Editors:

Polio A. EGFR mutated lung cancer: current therapies and potential future treatments. [Masters Thesis]. Boston University; 2015. Available from: http://hdl.handle.net/2144/13957


Vanderbilt University

8. Nebhan, Caroline Amalia. Acquired Resistance to Targeted Therapy in EGFR-Mutant Lung Adenocarcinoma.

Degree: PhD, Cancer Biology, 2014, Vanderbilt University

Lung cancer is the leading cause of cancer-related death in the United States and worldwide. Lung cancers that are driven by mutations in the Epidermal… (more)

Subjects/Keywords: acquired resistance; EGFR; targeted therapy; lung cancer

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Nebhan, C. A. (2014). Acquired Resistance to Targeted Therapy in EGFR-Mutant Lung Adenocarcinoma. (Doctoral Dissertation). Vanderbilt University. Retrieved from http://etd.library.vanderbilt.edu/available/etd-08312014-121626/ ;

Chicago Manual of Style (16th Edition):

Nebhan, Caroline Amalia. “Acquired Resistance to Targeted Therapy in EGFR-Mutant Lung Adenocarcinoma.” 2014. Doctoral Dissertation, Vanderbilt University. Accessed September 19, 2019. http://etd.library.vanderbilt.edu/available/etd-08312014-121626/ ;.

MLA Handbook (7th Edition):

Nebhan, Caroline Amalia. “Acquired Resistance to Targeted Therapy in EGFR-Mutant Lung Adenocarcinoma.” 2014. Web. 19 Sep 2019.

Vancouver:

Nebhan CA. Acquired Resistance to Targeted Therapy in EGFR-Mutant Lung Adenocarcinoma. [Internet] [Doctoral dissertation]. Vanderbilt University; 2014. [cited 2019 Sep 19]. Available from: http://etd.library.vanderbilt.edu/available/etd-08312014-121626/ ;.

Council of Science Editors:

Nebhan CA. Acquired Resistance to Targeted Therapy in EGFR-Mutant Lung Adenocarcinoma. [Doctoral Dissertation]. Vanderbilt University; 2014. Available from: http://etd.library.vanderbilt.edu/available/etd-08312014-121626/ ;


University of Manitoba

9. Xu, Minqi. Using next generation sequencing to detect clinically relevant oncogene mutations in lung cancer.

Degree: Pathology, 2017, University of Manitoba

 Introduction: Modern care of patients with lung cancer requires rapid and accurate diagnosis leading to personalized therapies for individual patients based on molecular characteristics of… (more)

Subjects/Keywords: next generation sequencing; lung cancer; ALK; EGFR

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Xu, M. (2017). Using next generation sequencing to detect clinically relevant oncogene mutations in lung cancer. (Masters Thesis). University of Manitoba. Retrieved from http://hdl.handle.net/1993/32390

Chicago Manual of Style (16th Edition):

Xu, Minqi. “Using next generation sequencing to detect clinically relevant oncogene mutations in lung cancer.” 2017. Masters Thesis, University of Manitoba. Accessed September 19, 2019. http://hdl.handle.net/1993/32390.

MLA Handbook (7th Edition):

Xu, Minqi. “Using next generation sequencing to detect clinically relevant oncogene mutations in lung cancer.” 2017. Web. 19 Sep 2019.

Vancouver:

Xu M. Using next generation sequencing to detect clinically relevant oncogene mutations in lung cancer. [Internet] [Masters thesis]. University of Manitoba; 2017. [cited 2019 Sep 19]. Available from: http://hdl.handle.net/1993/32390.

Council of Science Editors:

Xu M. Using next generation sequencing to detect clinically relevant oncogene mutations in lung cancer. [Masters Thesis]. University of Manitoba; 2017. Available from: http://hdl.handle.net/1993/32390


University of Minnesota

10. Sadhukha, Tanmoy. Targeted magnetic hyperthermia for lung cancer.

Degree: PhD, 2013, University of Minnesota

Lung cancer (specifically, non-small cell lung cancer; NSCLC) is the leading cause of cancer-related deaths in the United States. Poor response rates and survival with… (more)

Subjects/Keywords: Cancer stem cells; Lung cancer; Magnetic hyperthermia; Superparamagnetic iron oxide; Targeted drug delivery; Pharmaceutics

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Sadhukha, T. (2013). Targeted magnetic hyperthermia for lung cancer. (Doctoral Dissertation). University of Minnesota. Retrieved from http://hdl.handle.net/11299/168301

Chicago Manual of Style (16th Edition):

Sadhukha, Tanmoy. “Targeted magnetic hyperthermia for lung cancer.” 2013. Doctoral Dissertation, University of Minnesota. Accessed September 19, 2019. http://hdl.handle.net/11299/168301.

MLA Handbook (7th Edition):

Sadhukha, Tanmoy. “Targeted magnetic hyperthermia for lung cancer.” 2013. Web. 19 Sep 2019.

Vancouver:

Sadhukha T. Targeted magnetic hyperthermia for lung cancer. [Internet] [Doctoral dissertation]. University of Minnesota; 2013. [cited 2019 Sep 19]. Available from: http://hdl.handle.net/11299/168301.

Council of Science Editors:

Sadhukha T. Targeted magnetic hyperthermia for lung cancer. [Doctoral Dissertation]. University of Minnesota; 2013. Available from: http://hdl.handle.net/11299/168301


University of Western Australia

11. Webster, Rebecca. Complementary investigations of the molecular biology of cancer : assessment of the role of Grb7 in the proliferation and migration of breast cancer cells; and prediction and validation of microRNA targets involved in cancer.

Degree: PhD, 2007, University of Western Australia

 [Truncated abstract] For this thesis, the molecular biology of cancer was approached from two directions. Firstly, an investigation was conducted on the role of growth… (more)

Subjects/Keywords: Breast; Lungs; Cancer; Cancer; Growth factors; Lectins; Cancer cells; Cancer cells; MicroRNA; EGFR; Cancer

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Webster, R. (2007). Complementary investigations of the molecular biology of cancer : assessment of the role of Grb7 in the proliferation and migration of breast cancer cells; and prediction and validation of microRNA targets involved in cancer. (Doctoral Dissertation). University of Western Australia. Retrieved from http://repository.uwa.edu.au:80/R/?func=dbin-jump-full&object_id=10290&local_base=GEN01-INS01

Chicago Manual of Style (16th Edition):

Webster, Rebecca. “Complementary investigations of the molecular biology of cancer : assessment of the role of Grb7 in the proliferation and migration of breast cancer cells; and prediction and validation of microRNA targets involved in cancer.” 2007. Doctoral Dissertation, University of Western Australia. Accessed September 19, 2019. http://repository.uwa.edu.au:80/R/?func=dbin-jump-full&object_id=10290&local_base=GEN01-INS01.

MLA Handbook (7th Edition):

Webster, Rebecca. “Complementary investigations of the molecular biology of cancer : assessment of the role of Grb7 in the proliferation and migration of breast cancer cells; and prediction and validation of microRNA targets involved in cancer.” 2007. Web. 19 Sep 2019.

Vancouver:

Webster R. Complementary investigations of the molecular biology of cancer : assessment of the role of Grb7 in the proliferation and migration of breast cancer cells; and prediction and validation of microRNA targets involved in cancer. [Internet] [Doctoral dissertation]. University of Western Australia; 2007. [cited 2019 Sep 19]. Available from: http://repository.uwa.edu.au:80/R/?func=dbin-jump-full&object_id=10290&local_base=GEN01-INS01.

Council of Science Editors:

Webster R. Complementary investigations of the molecular biology of cancer : assessment of the role of Grb7 in the proliferation and migration of breast cancer cells; and prediction and validation of microRNA targets involved in cancer. [Doctoral Dissertation]. University of Western Australia; 2007. Available from: http://repository.uwa.edu.au:80/R/?func=dbin-jump-full&object_id=10290&local_base=GEN01-INS01


Cornell University

12. Sullivan, Kelly. Studies Of The Molecular Mechanisms Underlying Cancer Stem Cells And The Transformed Metabolic Phenotype .

Degree: 2015, Cornell University

 Intense research throughout recent decades has significantly expanded our knowledge of the complexities that make cancer a highly diverse and therapeutically challenging disease. Recently, cancer(more)

Subjects/Keywords: Cancer stem cells; Cancer metabolism; Cancer therapies

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Sullivan, K. (2015). Studies Of The Molecular Mechanisms Underlying Cancer Stem Cells And The Transformed Metabolic Phenotype . (Thesis). Cornell University. Retrieved from http://hdl.handle.net/1813/41119

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Sullivan, Kelly. “Studies Of The Molecular Mechanisms Underlying Cancer Stem Cells And The Transformed Metabolic Phenotype .” 2015. Thesis, Cornell University. Accessed September 19, 2019. http://hdl.handle.net/1813/41119.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Sullivan, Kelly. “Studies Of The Molecular Mechanisms Underlying Cancer Stem Cells And The Transformed Metabolic Phenotype .” 2015. Web. 19 Sep 2019.

Vancouver:

Sullivan K. Studies Of The Molecular Mechanisms Underlying Cancer Stem Cells And The Transformed Metabolic Phenotype . [Internet] [Thesis]. Cornell University; 2015. [cited 2019 Sep 19]. Available from: http://hdl.handle.net/1813/41119.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Sullivan K. Studies Of The Molecular Mechanisms Underlying Cancer Stem Cells And The Transformed Metabolic Phenotype . [Thesis]. Cornell University; 2015. Available from: http://hdl.handle.net/1813/41119

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


McMaster University

13. Yan, Judy. Characterizing prostate cancer stem-like cells and their contribution to prostate cancer tumorigenesis.

Degree: PhD, 2014, McMaster University

On average, 65 Canadian men will be diagnosed with prostate cancer (PC) every day, making it the most common male cancer in Canada. Despite the… (more)

Subjects/Keywords: Cancer; Cancer stem cells; Prostate Cancer

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Yan, J. (2014). Characterizing prostate cancer stem-like cells and their contribution to prostate cancer tumorigenesis. (Doctoral Dissertation). McMaster University. Retrieved from http://hdl.handle.net/11375/16285

Chicago Manual of Style (16th Edition):

Yan, Judy. “Characterizing prostate cancer stem-like cells and their contribution to prostate cancer tumorigenesis.” 2014. Doctoral Dissertation, McMaster University. Accessed September 19, 2019. http://hdl.handle.net/11375/16285.

MLA Handbook (7th Edition):

Yan, Judy. “Characterizing prostate cancer stem-like cells and their contribution to prostate cancer tumorigenesis.” 2014. Web. 19 Sep 2019.

Vancouver:

Yan J. Characterizing prostate cancer stem-like cells and their contribution to prostate cancer tumorigenesis. [Internet] [Doctoral dissertation]. McMaster University; 2014. [cited 2019 Sep 19]. Available from: http://hdl.handle.net/11375/16285.

Council of Science Editors:

Yan J. Characterizing prostate cancer stem-like cells and their contribution to prostate cancer tumorigenesis. [Doctoral Dissertation]. McMaster University; 2014. Available from: http://hdl.handle.net/11375/16285

14. S. Monterisi. HOXB7 IN LUNG CANCER: A NOVEL ROLE IN STEM CELL AND IPS BIOLOGY.

Degree: 2016, Università degli Studi di Milano

 Current diagnostic tools do not allow prognostic evaluation of patients with early stage lung cancer or selection of patients that might benefit from adjuvant chemotherapy.… (more)

Subjects/Keywords: HOXB7; LIN28B; CD90; Stem; Lung cancer; Homeobox; cancer stem cells; iPS; Settore MED/04 - Patologia Generale

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Monterisi, S. (2016). HOXB7 IN LUNG CANCER: A NOVEL ROLE IN STEM CELL AND IPS BIOLOGY. (Thesis). Università degli Studi di Milano. Retrieved from http://hdl.handle.net/2434/362619

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Monterisi, S.. “HOXB7 IN LUNG CANCER: A NOVEL ROLE IN STEM CELL AND IPS BIOLOGY.” 2016. Thesis, Università degli Studi di Milano. Accessed September 19, 2019. http://hdl.handle.net/2434/362619.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Monterisi, S.. “HOXB7 IN LUNG CANCER: A NOVEL ROLE IN STEM CELL AND IPS BIOLOGY.” 2016. Web. 19 Sep 2019.

Vancouver:

Monterisi S. HOXB7 IN LUNG CANCER: A NOVEL ROLE IN STEM CELL AND IPS BIOLOGY. [Internet] [Thesis]. Università degli Studi di Milano; 2016. [cited 2019 Sep 19]. Available from: http://hdl.handle.net/2434/362619.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Monterisi S. HOXB7 IN LUNG CANCER: A NOVEL ROLE IN STEM CELL AND IPS BIOLOGY. [Thesis]. Università degli Studi di Milano; 2016. Available from: http://hdl.handle.net/2434/362619

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Hong Kong

15. Kwan, Hoi-tung. Gremlin2 promotes the enrichment of CD44+ cancer stem cells after transarterial chemoembolization in the treatment of hepatocellular carcinoma.

Degree: PhD, 2014, University of Hong Kong

 Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide. While HCC patients at early stages are eligible for liver resection and liver transplantation,… (more)

Subjects/Keywords: Cancer cells; Liver - Cancer - Treatment; Stem cells

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Kwan, H. (2014). Gremlin2 promotes the enrichment of CD44+ cancer stem cells after transarterial chemoembolization in the treatment of hepatocellular carcinoma. (Doctoral Dissertation). University of Hong Kong. Retrieved from Kwan, H. [關愷彤]. (2014). Gremlin2 promotes the enrichment of CD44+ cancer stem cells after transarterial chemoembolization in the treatment of hepatocellular carcinoma. (Thesis). University of Hong Kong, Pokfulam, Hong Kong SAR. Retrieved from http://dx.doi.org/10.5353/th_b5719483 ; http://hdl.handle.net/10722/223620

Chicago Manual of Style (16th Edition):

Kwan, Hoi-tung. “Gremlin2 promotes the enrichment of CD44+ cancer stem cells after transarterial chemoembolization in the treatment of hepatocellular carcinoma.” 2014. Doctoral Dissertation, University of Hong Kong. Accessed September 19, 2019. Kwan, H. [關愷彤]. (2014). Gremlin2 promotes the enrichment of CD44+ cancer stem cells after transarterial chemoembolization in the treatment of hepatocellular carcinoma. (Thesis). University of Hong Kong, Pokfulam, Hong Kong SAR. Retrieved from http://dx.doi.org/10.5353/th_b5719483 ; http://hdl.handle.net/10722/223620.

MLA Handbook (7th Edition):

Kwan, Hoi-tung. “Gremlin2 promotes the enrichment of CD44+ cancer stem cells after transarterial chemoembolization in the treatment of hepatocellular carcinoma.” 2014. Web. 19 Sep 2019.

Vancouver:

Kwan H. Gremlin2 promotes the enrichment of CD44+ cancer stem cells after transarterial chemoembolization in the treatment of hepatocellular carcinoma. [Internet] [Doctoral dissertation]. University of Hong Kong; 2014. [cited 2019 Sep 19]. Available from: Kwan, H. [關愷彤]. (2014). Gremlin2 promotes the enrichment of CD44+ cancer stem cells after transarterial chemoembolization in the treatment of hepatocellular carcinoma. (Thesis). University of Hong Kong, Pokfulam, Hong Kong SAR. Retrieved from http://dx.doi.org/10.5353/th_b5719483 ; http://hdl.handle.net/10722/223620.

Council of Science Editors:

Kwan H. Gremlin2 promotes the enrichment of CD44+ cancer stem cells after transarterial chemoembolization in the treatment of hepatocellular carcinoma. [Doctoral Dissertation]. University of Hong Kong; 2014. Available from: Kwan, H. [關愷彤]. (2014). Gremlin2 promotes the enrichment of CD44+ cancer stem cells after transarterial chemoembolization in the treatment of hepatocellular carcinoma. (Thesis). University of Hong Kong, Pokfulam, Hong Kong SAR. Retrieved from http://dx.doi.org/10.5353/th_b5719483 ; http://hdl.handle.net/10722/223620


University of Hong Kong

16. Tang, Kwan-ho. Significance of IL-8 signaling in CD133 mediated tumor initiation and progression of hepatocellular carcinoma.

Degree: PhD, 2011, University of Hong Kong

 A novel theory in the field of tumor biology postulates that cancer growth is driven by a population of stem-like cells, called tumor-initiating cells (TICs).… (more)

Subjects/Keywords: Stem cells.; Liver - Cancer.; Cancer cells.

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Tang, K. (2011). Significance of IL-8 signaling in CD133 mediated tumor initiation and progression of hepatocellular carcinoma. (Doctoral Dissertation). University of Hong Kong. Retrieved from Tang, K. [鄧鈞豪]. (2011). Significance of IL-8 signaling in CD133 mediated tumor initiation and progression of hepatocellular carcinoma. (Thesis). University of Hong Kong, Pokfulam, Hong Kong SAR. Retrieved from http://dx.doi.org/10.5353/th_b4784978 ; http://dx.doi.org/10.5353/th_b4784978 ; http://hdl.handle.net/10722/174536

Chicago Manual of Style (16th Edition):

Tang, Kwan-ho. “Significance of IL-8 signaling in CD133 mediated tumor initiation and progression of hepatocellular carcinoma.” 2011. Doctoral Dissertation, University of Hong Kong. Accessed September 19, 2019. Tang, K. [鄧鈞豪]. (2011). Significance of IL-8 signaling in CD133 mediated tumor initiation and progression of hepatocellular carcinoma. (Thesis). University of Hong Kong, Pokfulam, Hong Kong SAR. Retrieved from http://dx.doi.org/10.5353/th_b4784978 ; http://dx.doi.org/10.5353/th_b4784978 ; http://hdl.handle.net/10722/174536.

MLA Handbook (7th Edition):

Tang, Kwan-ho. “Significance of IL-8 signaling in CD133 mediated tumor initiation and progression of hepatocellular carcinoma.” 2011. Web. 19 Sep 2019.

Vancouver:

Tang K. Significance of IL-8 signaling in CD133 mediated tumor initiation and progression of hepatocellular carcinoma. [Internet] [Doctoral dissertation]. University of Hong Kong; 2011. [cited 2019 Sep 19]. Available from: Tang, K. [鄧鈞豪]. (2011). Significance of IL-8 signaling in CD133 mediated tumor initiation and progression of hepatocellular carcinoma. (Thesis). University of Hong Kong, Pokfulam, Hong Kong SAR. Retrieved from http://dx.doi.org/10.5353/th_b4784978 ; http://dx.doi.org/10.5353/th_b4784978 ; http://hdl.handle.net/10722/174536.

Council of Science Editors:

Tang K. Significance of IL-8 signaling in CD133 mediated tumor initiation and progression of hepatocellular carcinoma. [Doctoral Dissertation]. University of Hong Kong; 2011. Available from: Tang, K. [鄧鈞豪]. (2011). Significance of IL-8 signaling in CD133 mediated tumor initiation and progression of hepatocellular carcinoma. (Thesis). University of Hong Kong, Pokfulam, Hong Kong SAR. Retrieved from http://dx.doi.org/10.5353/th_b4784978 ; http://dx.doi.org/10.5353/th_b4784978 ; http://hdl.handle.net/10722/174536


University of Hong Kong

17. 何永源; Ho, Wing-yuen. Identification and characterization of CD90⁺ cancer stem cells in hepatocellular carcinoma.

Degree: PhD, 2013, University of Hong Kong

 Hepatocellular carcinoma (HCC) is one of the most devastating malignancies worldwide with increasing incidences in both developed and developing countries. Survival rates have not been… (more)

Subjects/Keywords: Stem cells; Cancer cells; Liver - Cancer - Treatment

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

何永源; Ho, W. (2013). Identification and characterization of CD90⁺ cancer stem cells in hepatocellular carcinoma. (Doctoral Dissertation). University of Hong Kong. Retrieved from Ho, W. [何永源]. (2013). Identification and characterization of CD90⁺ cancer stem cells in hepatocellular carcinoma. (Thesis). University of Hong Kong, Pokfulam, Hong Kong SAR. Retrieved from http://dx.doi.org/10.5353/th_b5108670 ; http://dx.doi.org/10.5353/th_b5108670 ; http://hdl.handle.net/10722/193521

Chicago Manual of Style (16th Edition):

何永源; Ho, Wing-yuen. “Identification and characterization of CD90⁺ cancer stem cells in hepatocellular carcinoma.” 2013. Doctoral Dissertation, University of Hong Kong. Accessed September 19, 2019. Ho, W. [何永源]. (2013). Identification and characterization of CD90⁺ cancer stem cells in hepatocellular carcinoma. (Thesis). University of Hong Kong, Pokfulam, Hong Kong SAR. Retrieved from http://dx.doi.org/10.5353/th_b5108670 ; http://dx.doi.org/10.5353/th_b5108670 ; http://hdl.handle.net/10722/193521.

MLA Handbook (7th Edition):

何永源; Ho, Wing-yuen. “Identification and characterization of CD90⁺ cancer stem cells in hepatocellular carcinoma.” 2013. Web. 19 Sep 2019.

Vancouver:

何永源; Ho W. Identification and characterization of CD90⁺ cancer stem cells in hepatocellular carcinoma. [Internet] [Doctoral dissertation]. University of Hong Kong; 2013. [cited 2019 Sep 19]. Available from: Ho, W. [何永源]. (2013). Identification and characterization of CD90⁺ cancer stem cells in hepatocellular carcinoma. (Thesis). University of Hong Kong, Pokfulam, Hong Kong SAR. Retrieved from http://dx.doi.org/10.5353/th_b5108670 ; http://dx.doi.org/10.5353/th_b5108670 ; http://hdl.handle.net/10722/193521.

Council of Science Editors:

何永源; Ho W. Identification and characterization of CD90⁺ cancer stem cells in hepatocellular carcinoma. [Doctoral Dissertation]. University of Hong Kong; 2013. Available from: Ho, W. [何永源]. (2013). Identification and characterization of CD90⁺ cancer stem cells in hepatocellular carcinoma. (Thesis). University of Hong Kong, Pokfulam, Hong Kong SAR. Retrieved from http://dx.doi.org/10.5353/th_b5108670 ; http://dx.doi.org/10.5353/th_b5108670 ; http://hdl.handle.net/10722/193521


Rhodes University

18. Sterrenberg, Jason Neville. Molecular chaperone expression and function in breast cancer and breast cancer stem cells.

Degree: Faculty of Science, Biochemistry, Microbiology and Biotechnology, 2012, Rhodes University

 The Cancer Stem Cell (CSC) theory suggests that cancers arise from and are maintained by a subpopulation of cancer cells with stem cell properties. Molecular… (more)

Subjects/Keywords: Breast  – Cancer; Stem cells; Cancer cells

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Sterrenberg, J. N. (2012). Molecular chaperone expression and function in breast cancer and breast cancer stem cells. (Thesis). Rhodes University. Retrieved from http://hdl.handle.net/10962/d1016238

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Sterrenberg, Jason Neville. “Molecular chaperone expression and function in breast cancer and breast cancer stem cells.” 2012. Thesis, Rhodes University. Accessed September 19, 2019. http://hdl.handle.net/10962/d1016238.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Sterrenberg, Jason Neville. “Molecular chaperone expression and function in breast cancer and breast cancer stem cells.” 2012. Web. 19 Sep 2019.

Vancouver:

Sterrenberg JN. Molecular chaperone expression and function in breast cancer and breast cancer stem cells. [Internet] [Thesis]. Rhodes University; 2012. [cited 2019 Sep 19]. Available from: http://hdl.handle.net/10962/d1016238.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Sterrenberg JN. Molecular chaperone expression and function in breast cancer and breast cancer stem cells. [Thesis]. Rhodes University; 2012. Available from: http://hdl.handle.net/10962/d1016238

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


Universiteit Utrecht

19. Ampatziadis Michailidis, G. Cancer Stem Cells.

Degree: 2010, Universiteit Utrecht

Review on the Cancer Stem Cells (CSCs) theory. Topics include introduction on the stem cells and CSCs field. Moreover the CSCs are viewed under the blood malignancies and solid tumors (breast, brain, colorectal) classification. Advisors/Committee Members: Vries, Robert.

Subjects/Keywords: Geneeskunde; Cancer Stem Cells

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Ampatziadis Michailidis, G. (2010). Cancer Stem Cells. (Masters Thesis). Universiteit Utrecht. Retrieved from http://dspace.library.uu.nl:8080/handle/1874/179568

Chicago Manual of Style (16th Edition):

Ampatziadis Michailidis, G. “Cancer Stem Cells.” 2010. Masters Thesis, Universiteit Utrecht. Accessed September 19, 2019. http://dspace.library.uu.nl:8080/handle/1874/179568.

MLA Handbook (7th Edition):

Ampatziadis Michailidis, G. “Cancer Stem Cells.” 2010. Web. 19 Sep 2019.

Vancouver:

Ampatziadis Michailidis G. Cancer Stem Cells. [Internet] [Masters thesis]. Universiteit Utrecht; 2010. [cited 2019 Sep 19]. Available from: http://dspace.library.uu.nl:8080/handle/1874/179568.

Council of Science Editors:

Ampatziadis Michailidis G. Cancer Stem Cells. [Masters Thesis]. Universiteit Utrecht; 2010. Available from: http://dspace.library.uu.nl:8080/handle/1874/179568


University of Ottawa

20. Sulaiman, Andrew. New Approaches for the Treatment of Triple Negative Breast Cancer .

Degree: 2019, University of Ottawa

 Triple‐negative breast cancer (TNBC) is the most refractory subtype of breast cancer to current treatments and accounts disproportionately for the majority of breast cancer‐related deaths.… (more)

Subjects/Keywords: TNBC; Cancer Stem Cells

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Sulaiman, A. (2019). New Approaches for the Treatment of Triple Negative Breast Cancer . (Thesis). University of Ottawa. Retrieved from http://hdl.handle.net/10393/39100

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Sulaiman, Andrew. “New Approaches for the Treatment of Triple Negative Breast Cancer .” 2019. Thesis, University of Ottawa. Accessed September 19, 2019. http://hdl.handle.net/10393/39100.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Sulaiman, Andrew. “New Approaches for the Treatment of Triple Negative Breast Cancer .” 2019. Web. 19 Sep 2019.

Vancouver:

Sulaiman A. New Approaches for the Treatment of Triple Negative Breast Cancer . [Internet] [Thesis]. University of Ottawa; 2019. [cited 2019 Sep 19]. Available from: http://hdl.handle.net/10393/39100.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Sulaiman A. New Approaches for the Treatment of Triple Negative Breast Cancer . [Thesis]. University of Ottawa; 2019. Available from: http://hdl.handle.net/10393/39100

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Manitoba

21. Liang, Lisa. Functional characterization and selective targeting of CD271+ cells in sonic hedgehog medulloblastoma.

Degree: Biochemistry and Medical Genetics, 2019, University of Manitoba

 The extensive heterogeneity between and within medulloblastoma (MB) subgroups underscores a critical need for subtype-specific biomarkers and therapeutic strategies. Here, we employed a high throughput… (more)

Subjects/Keywords: Medulloblastoma; CD271; Cancer stem cells

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Liang, L. (2019). Functional characterization and selective targeting of CD271+ cells in sonic hedgehog medulloblastoma. (Thesis). University of Manitoba. Retrieved from http://hdl.handle.net/1993/33726

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Liang, Lisa. “Functional characterization and selective targeting of CD271+ cells in sonic hedgehog medulloblastoma.” 2019. Thesis, University of Manitoba. Accessed September 19, 2019. http://hdl.handle.net/1993/33726.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Liang, Lisa. “Functional characterization and selective targeting of CD271+ cells in sonic hedgehog medulloblastoma.” 2019. Web. 19 Sep 2019.

Vancouver:

Liang L. Functional characterization and selective targeting of CD271+ cells in sonic hedgehog medulloblastoma. [Internet] [Thesis]. University of Manitoba; 2019. [cited 2019 Sep 19]. Available from: http://hdl.handle.net/1993/33726.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Liang L. Functional characterization and selective targeting of CD271+ cells in sonic hedgehog medulloblastoma. [Thesis]. University of Manitoba; 2019. Available from: http://hdl.handle.net/1993/33726

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


Erasmus University Rotterdam

22. S.G. Roth (Sabrina). Silent Waters Run Deep. Quiescent stem cells in homeostasis and cancer.

Degree: 2012, Erasmus University Rotterdam

 markdownabstract__Abstract__ The Introduction summarizes the current literature on quiescence in adult stem cell niches and the various methods for the isolation of quiescent stem cells,… (more)

Subjects/Keywords: homeostasis; cancer; stem cells; gastroenterology

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

(Sabrina), S. R. (2012). Silent Waters Run Deep. Quiescent stem cells in homeostasis and cancer. (Thesis). Erasmus University Rotterdam. Retrieved from http://hdl.handle.net/1765/76036

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

(Sabrina), S.G. Roth. “Silent Waters Run Deep. Quiescent stem cells in homeostasis and cancer.” 2012. Thesis, Erasmus University Rotterdam. Accessed September 19, 2019. http://hdl.handle.net/1765/76036.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

(Sabrina), S.G. Roth. “Silent Waters Run Deep. Quiescent stem cells in homeostasis and cancer.” 2012. Web. 19 Sep 2019.

Vancouver:

(Sabrina) SR. Silent Waters Run Deep. Quiescent stem cells in homeostasis and cancer. [Internet] [Thesis]. Erasmus University Rotterdam; 2012. [cited 2019 Sep 19]. Available from: http://hdl.handle.net/1765/76036.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

(Sabrina) SR. Silent Waters Run Deep. Quiescent stem cells in homeostasis and cancer. [Thesis]. Erasmus University Rotterdam; 2012. Available from: http://hdl.handle.net/1765/76036

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


Texas Medical Center

23. lin, xiaofeng. THE ROLE OF TYROSINE PHOSPHORYLATION IN THE FUNCTIONS OF THE TUMOR SUPPRESSOR GPRC5A.

Degree: MS, 2010, Texas Medical Center

 The retinoic acid inducible G protein coupled receptor family C group 5 type A (GPRC5A) is expressed preferentially in normal lung tissue but its expression… (more)

Subjects/Keywords: GPRC5A; Tyrosine phosphorylation; EGFR; Cancer Biology; Cell Biology

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

lin, x. (2010). THE ROLE OF TYROSINE PHOSPHORYLATION IN THE FUNCTIONS OF THE TUMOR SUPPRESSOR GPRC5A. (Masters Thesis). Texas Medical Center. Retrieved from http://digitalcommons.library.tmc.edu/utgsbs_dissertations/79

Chicago Manual of Style (16th Edition):

lin, xiaofeng. “THE ROLE OF TYROSINE PHOSPHORYLATION IN THE FUNCTIONS OF THE TUMOR SUPPRESSOR GPRC5A.” 2010. Masters Thesis, Texas Medical Center. Accessed September 19, 2019. http://digitalcommons.library.tmc.edu/utgsbs_dissertations/79.

MLA Handbook (7th Edition):

lin, xiaofeng. “THE ROLE OF TYROSINE PHOSPHORYLATION IN THE FUNCTIONS OF THE TUMOR SUPPRESSOR GPRC5A.” 2010. Web. 19 Sep 2019.

Vancouver:

lin x. THE ROLE OF TYROSINE PHOSPHORYLATION IN THE FUNCTIONS OF THE TUMOR SUPPRESSOR GPRC5A. [Internet] [Masters thesis]. Texas Medical Center; 2010. [cited 2019 Sep 19]. Available from: http://digitalcommons.library.tmc.edu/utgsbs_dissertations/79.

Council of Science Editors:

lin x. THE ROLE OF TYROSINE PHOSPHORYLATION IN THE FUNCTIONS OF THE TUMOR SUPPRESSOR GPRC5A. [Masters Thesis]. Texas Medical Center; 2010. Available from: http://digitalcommons.library.tmc.edu/utgsbs_dissertations/79

24. Fabrizi, Eros. Identification of novel therapeutic targets for colon adenocarcinoma.

Degree: 2011, Università degli Studi di Catania

 Colorectal cancer (CRC) is the third most common form of cancer in the Western world. Despite the emergence of new targeted agents and the use… (more)

Subjects/Keywords: Colon cancer; Colon cancer stem cells

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Fabrizi, E. (2011). Identification of novel therapeutic targets for colon adenocarcinoma. (Thesis). Università degli Studi di Catania. Retrieved from http://hdl.handle.net/10761/95

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Fabrizi, Eros. “Identification of novel therapeutic targets for colon adenocarcinoma.” 2011. Thesis, Università degli Studi di Catania. Accessed September 19, 2019. http://hdl.handle.net/10761/95.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Fabrizi, Eros. “Identification of novel therapeutic targets for colon adenocarcinoma.” 2011. Web. 19 Sep 2019.

Vancouver:

Fabrizi E. Identification of novel therapeutic targets for colon adenocarcinoma. [Internet] [Thesis]. Università degli Studi di Catania; 2011. [cited 2019 Sep 19]. Available from: http://hdl.handle.net/10761/95.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Fabrizi E. Identification of novel therapeutic targets for colon adenocarcinoma. [Thesis]. Università degli Studi di Catania; 2011. Available from: http://hdl.handle.net/10761/95

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Southern California

25. Madhav, Anisha. The noncanonical role of telomerase in prostate cancer cells: exploring a non-telomeric signaling role for telomerase protein (TERT) in a cancer cell line.

Degree: MS, Biochemistry and Molecular Biology, 2012, University of Southern California

 The telomerase reverse transcriptase (TERT) component of telomerase has reverse transcriptase activity capable of elongating telomeres during each replication cycle of the cell. TERT plays… (more)

Subjects/Keywords: telomerase; TERT; prostate cancer; cancer stem cells

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Madhav, A. (2012). The noncanonical role of telomerase in prostate cancer cells: exploring a non-telomeric signaling role for telomerase protein (TERT) in a cancer cell line. (Masters Thesis). University of Southern California. Retrieved from http://digitallibrary.usc.edu/cdm/compoundobject/collection/p15799coll3/id/30249/rec/7025

Chicago Manual of Style (16th Edition):

Madhav, Anisha. “The noncanonical role of telomerase in prostate cancer cells: exploring a non-telomeric signaling role for telomerase protein (TERT) in a cancer cell line.” 2012. Masters Thesis, University of Southern California. Accessed September 19, 2019. http://digitallibrary.usc.edu/cdm/compoundobject/collection/p15799coll3/id/30249/rec/7025.

MLA Handbook (7th Edition):

Madhav, Anisha. “The noncanonical role of telomerase in prostate cancer cells: exploring a non-telomeric signaling role for telomerase protein (TERT) in a cancer cell line.” 2012. Web. 19 Sep 2019.

Vancouver:

Madhav A. The noncanonical role of telomerase in prostate cancer cells: exploring a non-telomeric signaling role for telomerase protein (TERT) in a cancer cell line. [Internet] [Masters thesis]. University of Southern California; 2012. [cited 2019 Sep 19]. Available from: http://digitallibrary.usc.edu/cdm/compoundobject/collection/p15799coll3/id/30249/rec/7025.

Council of Science Editors:

Madhav A. The noncanonical role of telomerase in prostate cancer cells: exploring a non-telomeric signaling role for telomerase protein (TERT) in a cancer cell line. [Masters Thesis]. University of Southern California; 2012. Available from: http://digitallibrary.usc.edu/cdm/compoundobject/collection/p15799coll3/id/30249/rec/7025

26. Alsulami, Mishal. Characterisation of human TDRD12 and LKAAEAR1 as potential oncogenic cancer testis antigen genes with clinical potential.

Degree: PhD, 2019, Bangor University

Cancer is a highly complex disease that evolved in response to a wide range of biological and molecular changes that impact disease behaviour, treatment efficacy… (more)

Subjects/Keywords: Cancer Testis antigens (CTA); Cancer stem cells

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Alsulami, M. (2019). Characterisation of human TDRD12 and LKAAEAR1 as potential oncogenic cancer testis antigen genes with clinical potential. (Doctoral Dissertation). Bangor University. Retrieved from https://research.bangor.ac.uk/portal/en/theses/characterisation-of-human-tdrd12-and-lkaaear1-as-potential-oncogenic-cancer-testis-antigen-genes-with-clinical-potential(2e569d4d-8a11-4bdf-9245-21f019a16ccb).html ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.767449

Chicago Manual of Style (16th Edition):

Alsulami, Mishal. “Characterisation of human TDRD12 and LKAAEAR1 as potential oncogenic cancer testis antigen genes with clinical potential.” 2019. Doctoral Dissertation, Bangor University. Accessed September 19, 2019. https://research.bangor.ac.uk/portal/en/theses/characterisation-of-human-tdrd12-and-lkaaear1-as-potential-oncogenic-cancer-testis-antigen-genes-with-clinical-potential(2e569d4d-8a11-4bdf-9245-21f019a16ccb).html ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.767449.

MLA Handbook (7th Edition):

Alsulami, Mishal. “Characterisation of human TDRD12 and LKAAEAR1 as potential oncogenic cancer testis antigen genes with clinical potential.” 2019. Web. 19 Sep 2019.

Vancouver:

Alsulami M. Characterisation of human TDRD12 and LKAAEAR1 as potential oncogenic cancer testis antigen genes with clinical potential. [Internet] [Doctoral dissertation]. Bangor University; 2019. [cited 2019 Sep 19]. Available from: https://research.bangor.ac.uk/portal/en/theses/characterisation-of-human-tdrd12-and-lkaaear1-as-potential-oncogenic-cancer-testis-antigen-genes-with-clinical-potential(2e569d4d-8a11-4bdf-9245-21f019a16ccb).html ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.767449.

Council of Science Editors:

Alsulami M. Characterisation of human TDRD12 and LKAAEAR1 as potential oncogenic cancer testis antigen genes with clinical potential. [Doctoral Dissertation]. Bangor University; 2019. Available from: https://research.bangor.ac.uk/portal/en/theses/characterisation-of-human-tdrd12-and-lkaaear1-as-potential-oncogenic-cancer-testis-antigen-genes-with-clinical-potential(2e569d4d-8a11-4bdf-9245-21f019a16ccb).html ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.767449


Rutgers University

27. Salman Noori, Faranak, 1986-. Stem cell-based ovarian cancer suicide gene therapy.

Degree: PhD, Pharmaceutical Science, 2015, Rutgers University

Cancer is a leading cause of death worldwide, resulting in 8.2 million deaths in 2012. Tumor suicide gene therapy is among the novel targeted therapeutics… (more)

Subjects/Keywords: Cancer – Gene therapy; Ovaries – Cancer; Stem cells

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Salman Noori, Faranak, 1. (2015). Stem cell-based ovarian cancer suicide gene therapy. (Doctoral Dissertation). Rutgers University. Retrieved from https://rucore.libraries.rutgers.edu/rutgers-lib/48643/

Chicago Manual of Style (16th Edition):

Salman Noori, Faranak, 1986-. “Stem cell-based ovarian cancer suicide gene therapy.” 2015. Doctoral Dissertation, Rutgers University. Accessed September 19, 2019. https://rucore.libraries.rutgers.edu/rutgers-lib/48643/.

MLA Handbook (7th Edition):

Salman Noori, Faranak, 1986-. “Stem cell-based ovarian cancer suicide gene therapy.” 2015. Web. 19 Sep 2019.

Vancouver:

Salman Noori, Faranak 1. Stem cell-based ovarian cancer suicide gene therapy. [Internet] [Doctoral dissertation]. Rutgers University; 2015. [cited 2019 Sep 19]. Available from: https://rucore.libraries.rutgers.edu/rutgers-lib/48643/.

Council of Science Editors:

Salman Noori, Faranak 1. Stem cell-based ovarian cancer suicide gene therapy. [Doctoral Dissertation]. Rutgers University; 2015. Available from: https://rucore.libraries.rutgers.edu/rutgers-lib/48643/

28. Vagulienė, Neringa. Sergančiųjų plaučių vėžiu lėtinio neinfekcinio uždegimo žymenų bei epidermio augimo veiksnio receptoriaus geno raiškos tyrimas.

Degree: PhD, Medicine, 2013, Lithuanian Academic Libraries Network (LABT)

Siekiant nustatyti patogenetinius plaučių vėžio ir LOPL mechanizmus, atsižvelgiant į šių ligų heterogeniškumą, mes šiame darbe nagrinėjome vietinio ir sisteminio lėtinio neinfekcinio uždegimo pokyčius sergant… (more)

Subjects/Keywords: Plaučių vėžys; Lėtinis neinfekcinis uždegimas; EGFR geno mutacijos; Lung cancer; Chronic inflammation; EGFR gene mutation

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Vagulienė, N. (2013). Sergančiųjų plaučių vėžiu lėtinio neinfekcinio uždegimo žymenų bei epidermio augimo veiksnio receptoriaus geno raiškos tyrimas. (Doctoral Dissertation). Lithuanian Academic Libraries Network (LABT). Retrieved from http://vddb.laba.lt/obj/LT-eLABa-0001:E.02~2013~D_20131106_091107-56522 ;

Chicago Manual of Style (16th Edition):

Vagulienė, Neringa. “Sergančiųjų plaučių vėžiu lėtinio neinfekcinio uždegimo žymenų bei epidermio augimo veiksnio receptoriaus geno raiškos tyrimas.” 2013. Doctoral Dissertation, Lithuanian Academic Libraries Network (LABT). Accessed September 19, 2019. http://vddb.laba.lt/obj/LT-eLABa-0001:E.02~2013~D_20131106_091107-56522 ;.

MLA Handbook (7th Edition):

Vagulienė, Neringa. “Sergančiųjų plaučių vėžiu lėtinio neinfekcinio uždegimo žymenų bei epidermio augimo veiksnio receptoriaus geno raiškos tyrimas.” 2013. Web. 19 Sep 2019.

Vancouver:

Vagulienė N. Sergančiųjų plaučių vėžiu lėtinio neinfekcinio uždegimo žymenų bei epidermio augimo veiksnio receptoriaus geno raiškos tyrimas. [Internet] [Doctoral dissertation]. Lithuanian Academic Libraries Network (LABT); 2013. [cited 2019 Sep 19]. Available from: http://vddb.laba.lt/obj/LT-eLABa-0001:E.02~2013~D_20131106_091107-56522 ;.

Council of Science Editors:

Vagulienė N. Sergančiųjų plaučių vėžiu lėtinio neinfekcinio uždegimo žymenų bei epidermio augimo veiksnio receptoriaus geno raiškos tyrimas. [Doctoral Dissertation]. Lithuanian Academic Libraries Network (LABT); 2013. Available from: http://vddb.laba.lt/obj/LT-eLABa-0001:E.02~2013~D_20131106_091107-56522 ;


Wright State University

29. Kovar, Sarah E. Discovery of small molecules blocking oncogenic K-Ras activity.

Degree: MS, Biochemistry and Molecular Biology, 2018, Wright State University

 Ras proteins were the first human oncogenes discovered. Although Ras has been found to be the most frequently mutated oncogene, there are currently no anti-Ras-specific… (more)

Subjects/Keywords: Biochemistry; Molecular Biology; K-Ras; oncogenic Ras; K-Ras Ser181; phosphorylation; signal transduction; non-small cell lung cancer cells

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Kovar, S. E. (2018). Discovery of small molecules blocking oncogenic K-Ras activity. (Masters Thesis). Wright State University. Retrieved from http://rave.ohiolink.edu/etdc/view?acc_num=wright1533299266181661

Chicago Manual of Style (16th Edition):

Kovar, Sarah E. “Discovery of small molecules blocking oncogenic K-Ras activity.” 2018. Masters Thesis, Wright State University. Accessed September 19, 2019. http://rave.ohiolink.edu/etdc/view?acc_num=wright1533299266181661.

MLA Handbook (7th Edition):

Kovar, Sarah E. “Discovery of small molecules blocking oncogenic K-Ras activity.” 2018. Web. 19 Sep 2019.

Vancouver:

Kovar SE. Discovery of small molecules blocking oncogenic K-Ras activity. [Internet] [Masters thesis]. Wright State University; 2018. [cited 2019 Sep 19]. Available from: http://rave.ohiolink.edu/etdc/view?acc_num=wright1533299266181661.

Council of Science Editors:

Kovar SE. Discovery of small molecules blocking oncogenic K-Ras activity. [Masters Thesis]. Wright State University; 2018. Available from: http://rave.ohiolink.edu/etdc/view?acc_num=wright1533299266181661


Uppsala University

30. Mattsson, Johanna. Genetic heterogeneity of EGFR and KRAS mutations in primary tumor tissue from non-small cell lung cancer patients.

Degree: Medical Biochemistry and Microbiology, 2011, Uppsala University

  Activated epidermal growth factor receptor (EGFR) and Kirsten rat sarcoma viral oncogene homolog (KRAS) mutations characterize molecular subgroups of non-small cell lung cancer (NSCLC)… (more)

Subjects/Keywords: Non-small cell lung cancer; KRAS; EGFR; heterogeneity; mutation

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Mattsson, J. (2011). Genetic heterogeneity of EGFR and KRAS mutations in primary tumor tissue from non-small cell lung cancer patients. (Thesis). Uppsala University. Retrieved from http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-159359

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Mattsson, Johanna. “Genetic heterogeneity of EGFR and KRAS mutations in primary tumor tissue from non-small cell lung cancer patients.” 2011. Thesis, Uppsala University. Accessed September 19, 2019. http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-159359.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Mattsson, Johanna. “Genetic heterogeneity of EGFR and KRAS mutations in primary tumor tissue from non-small cell lung cancer patients.” 2011. Web. 19 Sep 2019.

Vancouver:

Mattsson J. Genetic heterogeneity of EGFR and KRAS mutations in primary tumor tissue from non-small cell lung cancer patients. [Internet] [Thesis]. Uppsala University; 2011. [cited 2019 Sep 19]. Available from: http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-159359.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Mattsson J. Genetic heterogeneity of EGFR and KRAS mutations in primary tumor tissue from non-small cell lung cancer patients. [Thesis]. Uppsala University; 2011. Available from: http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-159359

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

[1] [2] [3] [4] [5] … [1582]

.